Katja Rosenkranz

Katja is a Partner at V-Bio Ventures, a pan-European venture fund dedicated to investments into early stage medicines and therapeutic platforms with breakthrough potential. Katja is on the Boards of AgomAb and dualyx. She previously served on the Boards of Omeicos and amcure.

Before joining V-Bio Ventures in 2016, Katja spent more than 12 years in the life science venture business, worked as an analyst at PolyTechnos Venture-Partners and as CBO/CFO at Hepa Wash. Subsequently, Katja was a senior investment and project manager at Ascenion, where she managed the Spinnovator initiative to progress early academic inventions into spin-offs (a.o. Omeicos, Cardior, HepaRegeniX, amcure). Katja holds a PhD and MSc in Biochemistry and an Executive MBA in Medical Devices and Healthcare Management.

In her free time, she enjoys hiking/climbing, dancing and Ashtanga yoga.